Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Takeda Pharmaceutical Ltd ADR
(NY:
TAK
)
13.57
-0.12 (-0.91%)
Streaming Delayed Price
Updated: 11:11 AM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Ltd ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Monday Markets Unhinged
May 03, 2021
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan.
Via
Talk Markets
Another Heavy News Day
April 29, 2021
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.
Via
Talk Markets
Arrowhead's ARO-AAT Treatment Associated With Improved Fibrosis In Patients With Alpha-1 Liver Disease
April 28, 2021
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has announced positive interim 48-week liver biopsy results from the Phase 2 AROAAT2002 study ...
Via
Benzinga
Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year
April 28, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer
April 27, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Down Nearly 50% From All-Time Highs, Is This Pharma Giant a Good Buy?
April 24, 2021
You might want to consider adding this company to your portfolio.
Via
The Motley Fool
Friday Market Report
April 23, 2021
Schlumberger Ltd of Curação today reported on its Q1 results which were good.
Via
Talk Markets
Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions
April 19, 2021
Ovid Therapeutics Inc (NASDAQ: OVID) has announced to discontinue the development of OV101 (gaboxadol), a delta (δ)-selective GABAA receptor agonist, in...
Via
Benzinga
Electric Cancer Cure
April 13, 2021
Most US stocks were down on fear of inflation and financial risks but then rose after lunch.
Via
Talk Markets
Takeda Manufacturing Site in Belgium Pioneering Wastewater Recycling for Production
April 13, 2021
SOURCE: Takeda
Via
3BL Media
Daily Stock Analysis: Takeda Pharmaceutical (TAK)
April 09, 2021
Takeda Pharmaceutical Co Ltd's price per share closed at $17.06 yesterday. One year ago its price was $16.05. Price per share has increased about 6.3% from the midst of the COVID market slump.
Via
Talk Markets
Weak Markets - Yom HaShoah
April 07, 2021
Today the Biden Administration revealed its planned changes in the corporate tax code.
Via
Talk Markets
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.